The US FDA has approved a fourth product via its new National Priority Voucher Programme — a 7.2 mg dose of Novo Nordisk’s weight loss

Verily has raised $300 million in new, outside funding that ends parent company Alphabet’s controlling position in the healthcare innovation company, Endpoints News has learned

TerraPower Isotopes, a subsidiary of founder Bill Gates’ nuclear company TerraPower, is building an actinium-225 factory in Philadelphia. Production will start in 2029. TerraPower Isotopes

CSL Behring disclosed a “temporary global stockout” of its gene therapy for hemophilia B that it says could delay treatment for some patients. In a

AstraZeneca has added more details on how it will use its $15 billion budget to expand in China — and the UK pharma is betting